MDLN Medline Inc. stock chart & analysis

Conviction 17HealthcareScan · Fri, Nov 6, 2026

Medline Inc. (MDLN) closed at $39.64 (-0.30%) on Nov 6, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 69, -22.1% from its 52-week high, -5.6% year to date. Sector: Healthcare · Surgical & Medical Instruments & Apparatus.

MDLN$39.64-0.30%

ResistanceSupportVol 14Insider buyInsider sell

Loading chart…

Medline Inc.Surgical & Medical Instruments & Apparatuswww.medline.com ↗

Price39.64

Change-0.30%

Gap-0.06%

Rel volume0.74×

Avg volume10.2M

Avg $ vol361.7M

SMA 2035.24

SMA 5034.78

SMA 20039.48

Price vs 50+14.00%

Price vs 200+0.42%

MA stackmixed

50/200 cross—

Supertrendup · 34.72

RSI (14)69

MACD hist0.69

MACD crossbull · 2d

Stoch %K / %D81 / 86

ADX (14)23

+DI / −DI41 / 16

RSI divergence—

MACD divergence—

ATR %4.18%

ADR %3.76%

52w high50.88

52w low31.37

From 52w high-22.07%

Above 52w low+26.39%

New 52w highNo

SqueezeOff

Bollinger width27.06%

%B0.96

Donchian pos80.94%

Donchian high41.60

Donchian low31.37

AVWAP (52w high)37.99

vs AVWAP high+4.36%

AVWAP (52w low)36.63

vs AVWAP low+8.24%

OBV trendDown

Chaikin MF (20)0.09

Today vs 20d0.74×

Avg vol (14d)12.04M

Avg vol (20d)10.2M

Avg $ vol (20d)361.7M

Market cap32.12B

RS Rating—

RS 3m (vs SPY)+22.14%

RS 6m (vs SPY)+0.63%

RS line new highNo

Trend template—

Technical rank78.3

1 week+23.44%

1 month+10.94%

3 months+17.27%

6 months+0.33%

1 year—

YTD-5.60%

P/E—

P/B2.72

P/S1.13

P/FCF24.76

EPS-0.0100

Div yield—

ROE—

ROA—

Debt/Eq1.07

Current4.04

EV/EBITDA13.15

Gross margin26.44%

Net margin—

Rev growth11.47%

EPS growth-0.86%

Price target46.44

Target upside17.12%

Analyst ratingBuy

Institutional101.73%

Ent. value42.37B

Revenue7.86B

Net income318M

Gross profit1.93B

Free cash flow1.3B

IndustrySurgical & Medical Instruments & Apparatus

ExchangeNasdaq

Shares out845.61M

Employees45K

ListedWed, Dec 17, 2025

Free float226.53M

Float %28.8%

Short interest—

Days to cover—

Short volume49.8%

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est$0.42 vs $0.32

Last surprise+31.3% beat

Setup gradeD

Conviction17 / 100

Pattern quality—

Tech rank78.3 / 100

Group rank23 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance36.95

Support31.43

Days since event—

Candle confirm—

Financials as of Sat, Sep 26, 2026 · quarterly.

MDLN technical analysis

Trend

MDLN's moving averages are mixed — no clean uptrend or downtrend. It closed 14.0% above the 50-day ($34.78) and 0.4% above the 200-day ($39.48). ADX(14) at 23 points to a moderate trend.

Momentum

RSI(14) is 69, in the bullish half of its range. MACD crossed above its signal line 2 sessions ago.

Volume and volatility

Volume on the latest session ran 0.7× its 20-day average. It trades about $361.7M a day on average. ATR(14) is $1.66, 4.2% of price — its typical daily range. On-balance volume is trending down. Chaikin Money Flow (0.09) shows accumulation.

Key levels

The chart pattern's support is $31.43 and its resistance $36.95. The 52-week range is $31.37 to $50.88; price is 22.1% below the high and 26.4% above the low. The VWAP anchored at the 52-week high is $37.99, below price.

Performance

MDLN returned +23.4% (1 week), +10.9% (1 month), +17.3% (3 months), +0.3% (6 months), -5.6% (year to date).

About Medline Inc.

Medline is the largest provider of medical-surgical products and supply chain solutions in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front-line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.

Surgical & Medical Instruments & Apparatus · Listed 2025 · 45,000 employees

Insider activity

SEC Form 4 transactions in MDLN · open-market 5 sells

Insider	Side	Shares	Value	Traded	Filed
Miller Stephen L Chief Operating Officer · Incentive Units of Medline Holdings, LP · 2026-08-19	Grant	87.67K	—	2026-08-19	2026-08-21
Boyle James M Chief Executive Officer · Incentive Units of Medline Holdings, LP · 2026-08-19	Grant	764.25K	—	2026-08-19	2026-08-21
GIC Private Ltd 10% owner · Class A Common Stock · 2026-08-14	Sell	100K	$3.6M	2026-08-14	2026-08-17
GIC Private Ltd 10% owner · Class A Common Stock · 2026-08-13	Sell	1.5M	$54M	2026-08-13	2026-08-17
GIC Private Ltd 10% owner · Class A Common Stock · 2026-08-07	Sell	590.28K	$21M	2026-08-07	2026-08-11
GIC Private Ltd 10% owner · Class A Common Stock · 2026-08-06	Sell	271.99K	$9.6M	2026-08-06	2026-08-07
Mozart Holdco, Inc. 10% owner · Class A Common Stock · 2026-08-06	Convert	500K	—	2026-08-06	2026-08-07
Mozart Holdco, Inc. 10% owner · Common Units of Medline Holdings, LP · 2026-08-06	Convert	500K	—	2026-08-06	2026-08-07
Mozart Holdco, Inc. 10% owner · Class B Common Stock · 2026-08-06	Dispose	500K	—	2026-08-06	2026-08-07
GIC Private Ltd 10% owner · Class A Common Stock · 2026-08-05	Sell	1.71M	$61M	2026-08-05	2026-08-07

SEC filings

EDGAR filings in MDLN · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.

Start free — 7-day trial, no card →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.